Amniocentesis Needle Market

[132 Pages Report] The amniocentesis Needles market is expected to reach USD 172.8 million by 2022 from USD 146.4 million in 2016 at a CAGR of 2.8%. The base year for this study is 2016 and the forecast period is 2017–2022. 100–150 mm needles are the most commonly used amniocentesis needles and are expected to account for the largest share of the global market in 2017. The large share of this segment can be attributed to the fact that these needles are suitable for most patients on account of their optimal length.

Market Dynamics

Drivers

• High reliability of amniocentesis
• Growth in the median age of first-time motherhood
• Heavy burden of congenital disorders

Restraints

• Availability of alternative methods

Challenges

• Shortage of skilled proffessionals

Use of amniocentesis needles in amniocentesis procedures drives the global 100–150 mm needles market

This type of needle is suitable for use in females with a normal body-mass index (BMI) of 18.50–24.99 kg/m2. There is an increase in the proportion of women who are overweight, this proportion will still be lesser than the proportion of women with normal BMI. This is one of the major factors responsible for the large share of 100–150 mm needles in the amniocentesis needles market. Amniocentesis procedure is the most commonly recommended invasive prenatal diagnostic test to detect chromosomal disorders, infections, or birth defects. In spite of a small proportion of risks associated with this procedure, amniocentesis is carried out to diagnose the abnormalities in the developing fetus. These are the major factors responsible for the large share of this procedure segment in the amniocentesis needles market.

The following are the major objectives of the study:

• To define, describe, segment, and forecast the amniocentesis needles market on the basis of type, procedure, end user, and region
• To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)
• To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market
• To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To profile the key players and comprehensively analyze their market position and core competencies in terms of market developments and growth strategies
• To track and analyze competitive developments such as partnerships, agreements, collaborations, and joint ventures; mergers and acquisitions; product launches; and research and development activities in the amniocentesis needles market

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation—by type, procedure, end user, and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Various secondary sources such as World Health Organization, National Institutes of Health, Eurostat, U.S. Food and Drug Administration, Centers for Disease Control and Prevention, European Diagnostic Manufacturers Association, World Bank, International Society for Prenatal Diagnosis, Centers for Disease Control and Prevention, Society for Maternal-Fetal Medicine, American Congress of Obstetricians and Gynecologists, European Commission, and European Centre for Disease Prevention and Control have been used to identify and collect information useful for this extensive commercial study of the amniocentesis needles market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the amniocentesis needles market. The breakdown of profiles of primaries is shown in the figure below:

The key players in the amniocentesis needles market include Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), Cook Medical (US), Laboratoire CCD (France), Biopsybell (Italy), RI.MOS. (Italy), TSUNAMI MEDICAL (Italy), and Rocket Medical (UK).

Major Market Developments

1. In 2018, Medline Industries, Inc. (US) completed the acquisition of  Centurion Medical Products (US) to provide a complete set of offerings that complement its minor procedure tray kits and its growing infection prevention focus
2. In 2016, CooperSurgical (US) completed the acquisition of Wallace, the in-vitro fertilization (IVF) segment of Smiths Medical, a division of Smiths Group plc, to strengthen product portfolio and takeover premier products for women’s health
3. In 2017, Medtronic established an innovation center in Chengdu, China to provide advanced training to medical workers in Central and Western China
4. In 2016, Medline shifted its corporate headquarters to a new, state-of-the-art facility which is more than double the size of its current space with a view to adapt to the needs of the rapidly changing healthcare.

Target Audience for this Report:

• Manufacturers and vendors of amniocentesis needles
• Hospitals
• Diagnostic centers
• Private clinics
• Research associations related to amniocentesis needles
• Various research and consulting firms
• Distributors of amniocentesis needles
• Contract research manufacturers of amniocentesis needles
• Research institutes
• Government bodies
• Amniocentesis needles database and software providers
• Venture capitalists

Want to explore hidden markets that can drive new revenue in Amniocentesis Needle Market?

Unlock Insights

Scope of the Report

:

This report categorizes the amniocentesis needles market into the following segments:

By Type

• 100–150 mm
• Larger than 150 mm
• Smaller than 100 mm

By Procedure

• Amniocentesis
• Amnioreduction
• Fetal Blood Transfusion
• Amnioinfusion
• Cordocentesis

By End User

• Hospitals
• Diagnostic Centers
• Clinics
• Other End Users

By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Rest of Europe
• Asia
• Rest of the World

Critical questions which the report answers

• What are new application areas which the amniocentesis needles companies are exploring?
• Which are the key players in the market and how intense is the competition?

Customization Options:

• Company Information: Detailed company profiles of five or more market players
• Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

The global amniocentesis needles market is expected to reach USD 172.8 million by 2022 from USD 150.6 million in 2017, at a CAGR of 2.8%. The high reliability of the amniocentesis technique, rise in the median age of first-time motherhood, and increasing burden of congenital disorders are key factors driving the growth of this market.

The global amniocentesis needles market is segmented by type, procedure, end user, and regions. By type, the amniocentesis needles market is segmented into needles of length 100–150 mm, larger than 150 mm, and smaller than 100 mm. The 100–150 mm segment is estimated to account for the largest market share of the global amniocentesis needles market in 2017. Factors driving the growth of this segment include the widespread use of these needles on account of their optimal length and suitability of use for most patients.

By procedure, the market is classified into amniocentesis, amnioreduction, fetal blood transfusion, amnioinfusion, and cordocentesis. The amniocentesis segment is estimated to account for the largest share of the global amniocentesis needles market during the next five years. High reliability of the amniocentesis technique and the extensive use of this procedure to diagnose the abnormalities in the developing fetus are driving the growth of this market.

On the basis of end user, the amniocentesis needles market is segmented into hospitals, diagnostic centers, clinics, and other end users. The hospitals segment is estimated to account for the largest share of the global amniocentesis needles market during the forecast period. Growth in the number of hospitals coupled with better accessibility and availability of test results in hospitals are major factors driving the growth of this end-user segment.

The global amniocentesis needles market is dominated by North America, followed by Europe. North America will continue to dominate the global amniocentesis needles market during the forecast period. Factors such as the rising government initiatives and increasing healthcare expenditure are driving the growth of the amniocentesis needles market in this region.

The availability of alternate methods for prenatal diagnosis may restrain market growth to a certain extent.

Amniocentesis procedures and amniodreduction procedures will drive the overall growth of amiocentesis needles market

Amniocentesis Procedures

Amniocentesis is an invasive procedure in which a portion of the amniotic fluid is withdrawn from the uterus using an amniocentesis needle. This fluid contains the cells shed by the fetus and certain chemicals produced by the baby, which can be used as a sample to detect chromosomal disorders, infections, or birth defects. Globally, maternal age is increasing on account of changing lifestyles, which is expected to lead to an increase in the burden of chromosomal abnormalities. Furthermore, there is an average increase in the body mass index of women, which may decrease the specificity of the non-invasive screening methods. Thus, the increasing burden of chromosomal disorders, increasing maternal age and BMI, and high reliability of amniocentesis technique are the major factors contributing to the growth of this market.

Amnioreduction Procedures

Amnioreduction is a procedure performed to remove the excess amount of amniotic fluid from the gestational sac. In this procedure, the fluid is withdrawn by inserting an amniocentesis needle under Ultrasound guidance and withdrawing the fluid manually or with the help of vacuum tubing and vacuum bottles.

Critical questions the report answers:

• Where will all these developments take the industry in the mid to long term?
• What are the upcoming industry applications for amniocentesis needles?

The availability of alternate methods is expected to limit market growth to a certain extent. Apart from amniocentesis, there are invasive as well as non-invasive techniques for screening and diagnosing fetal disorders or diseases. Invasive tests include chorionic villus sampling (CVS) and cordocentesis. CVS is preferred over amniocentesis as it is performed at an earlier stage of pregnancy and there is more time available to consider the results and take a final decision. However, there is a low probability of miscarriage associated with invasive tests, which may result in the reduced adoption of these tests. Non-invasive tests include blood tests, ultrasound measurements, and genomics-based non-invasive prenatal testing. These tests are preferred as there is no risk of miscarriage associated with them.

Major industry players acquired companies and business units from other companies to maintain and improve their position in the Amniocentesis Needles Market. Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), and Cook Medical (US) have been identified as the key players in this market. These companies have a broad product portfolio with comprehensive features. These leaders have products for all end users in this market, and have a strong geographical presence.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst